Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

CTXR Citius Pharmaceuticals Inc

0,6776

0,0143 (2,16%)

Zuletzt aktualisiert: 16:02:08

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Citius Pharmaceuticals (NASDAQ:CTXR)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Citius Pharmaceuticals Charts.

Citius Pharmaceuticals (NASDAQ:CTXR)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Citius Pharmaceuticals Charts.

News Citius Pharmaceuticals Inc

Citius Pharmaceuticals Announces Closing of $15 Million Registered Direct Offering
Dienstag 30 April 2024 (1 Woche vor) • PR Newswire (US)

Citius Pharmaceuticals Announces $15 Million Registered Direct Offering
Freitag 26 April 2024 (2 Wochen vor) • PR Newswire (US)

Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Donnerstag 11 April 2024 (4 Wochen vor) • PR Newswire (US)

Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference
Donnerstag 4 April 2024 (1 Monat vor) • PR Newswire (US)

Citius Pharmaceuticals Announces FDA Acceptance of the BLA Resubmission of LYMPHIR™ (Denileukin Diftitox) for the Treatment of Adults with Relapsed or Refractory Cutaneous T-Cell Lymphoma
Montag 18 März 2024 (2 Monate vor) • PR Newswire (US)

Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program
Donnerstag 7 März 2024 (2 Monate vor) • PR Newswire (US)

Form EFFECT - Notice of Effectiveness
Montag 4 März 2024 (2 Monate vor) • Edgar (US Regulatory)

Citius Pharmaceuticals Announces Filing of Form S-3 Shelf Registration Statement to Replace Expiring Prior Shelf Registration
Montag 26 Februar 2024 (2 Monate vor) • PR Newswire (US)

Form S-3 - Registration statement under Securities Act of 1933
Freitag 23 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Freitag 23 Februar 2024 (2 Monate vor) • Edgar (US Regulatory)

Citius Pharmaceuticals to Participate in Upcoming BIO CEO and Sidoti Investor Conferences
Freitag 23 Februar 2024 (2 Monate vor) • PR Newswire (US)

Form 8-K - Current report
Donnerstag 15 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Citius Pharmaceuticals Inc News-Artikel

Invesco QQQ Trust Series 1

Deutsche Lufthansa

Deutsche Telekom (QX)

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen